Cost Of Revenues

3 Months Ended

Mar. 31, 2013

Other Cost and Expense Disclosure, Operating [Abstract]

Cost Of Revenues

NOTE 14. COST OF REVENUES

The components of Cost of revenues for the three months ended March 31, 2013 and 2012 (in thousands) were as follows:

	Three Months Ended March 31,
	2013		2012
Cost of net pharmaceutical product sales	$	217,267	$	290,595
Cost of device revenues	37,114		41,545
Cost of service and other revenues	31,545		32,680
Total cost of revenues	$	285,926	$	364,820